Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).
Identifieur interne : 003733 ( Ncbi/Merge ); précédent : 003732; suivant : 003734Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).
Auteurs : Samuel James Brake [Australie] ; Kathryn Barnsley [Australie] ; Wenying Lu [Australie] ; Kielan Darcy Mcalinden [Australie] ; Mathew Suji Eapen [Australie] ; Sukhwinder Singh Sohal [Australie]Source :
- Journal of clinical medicine [ 2077-0383 ] ; 2020.
Abstract
The epicenter of the original outbreak in China has high male smoking rates of around 50%, and early reported death rates have an emphasis on older males, therefore the likelihood of smokers being overrepresented in fatalities is high. In Iran, China, Italy, and South Korea, female smoking rates are much lower than males. Fewer females have contracted the virus. If this analysis is correct, then Indonesia would be expected to begin experiencing high rates of Covid-19 because its male smoking rate is over 60% (Tobacco Atlas). Smokers are vulnerable to respiratory viruses. Smoking can upregulate angiotensin-converting enzyme-2 (ACE2) receptor, the known receptor for both the severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV) and the human respiratory coronavirus NL638. This could also be true for new electronic smoking devices such as electronic cigarettes and "heat-not-burn" IQOS devices. ACE2 could be a novel adhesion molecule for SARS-CoV-2 causing Covid-19 and a potential therapeutic target for the prevention of fatal microbial infections, and therefore it should be fast tracked and prioritized for research and investigation. Data on smoking status should be collected on all identified cases of Covid-19.
DOI: 10.3390/jcm9030841
PubMed: 32244852
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000364
- to stream PubMed, to step Curation: 000364
- to stream PubMed, to step Checkpoint: 000182
Links to Exploration step
pubmed:32244852Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).</title><author><name sortKey="Brake, Samuel James" sort="Brake, Samuel James" uniqKey="Brake S" first="Samuel James" last="Brake">Samuel James Brake</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author><author><name sortKey="Barnsley, Kathryn" sort="Barnsley, Kathryn" uniqKey="Barnsley K" first="Kathryn" last="Barnsley">Kathryn Barnsley</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, University of Tasmania, Hobart, Tasmania 7001, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Medicine, University of Tasmania, Hobart, Tasmania 7001</wicri:regionArea><wicri:noRegion>Tasmania 7001</wicri:noRegion></affiliation></author><author><name sortKey="Lu, Wenying" sort="Lu, Wenying" uniqKey="Lu W" first="Wenying" last="Lu">Wenying Lu</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author><author><name sortKey="Mcalinden, Kielan Darcy" sort="Mcalinden, Kielan Darcy" uniqKey="Mcalinden K" first="Kielan Darcy" last="Mcalinden">Kielan Darcy Mcalinden</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author><author><name sortKey="Eapen, Mathew Suji" sort="Eapen, Mathew Suji" uniqKey="Eapen M" first="Mathew Suji" last="Eapen">Mathew Suji Eapen</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author><author><name sortKey="Sohal, Sukhwinder Singh" sort="Sohal, Sukhwinder Singh" uniqKey="Sohal S" first="Sukhwinder Singh" last="Sohal">Sukhwinder Singh Sohal</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32244852</idno><idno type="pmid">32244852</idno><idno type="doi">10.3390/jcm9030841</idno><idno type="wicri:Area/PubMed/Corpus">000364</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000364</idno><idno type="wicri:Area/PubMed/Curation">000364</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000364</idno><idno type="wicri:Area/PubMed/Checkpoint">000182</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000182</idno><idno type="wicri:Area/Ncbi/Merge">003733</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).</title><author><name sortKey="Brake, Samuel James" sort="Brake, Samuel James" uniqKey="Brake S" first="Samuel James" last="Brake">Samuel James Brake</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author><author><name sortKey="Barnsley, Kathryn" sort="Barnsley, Kathryn" uniqKey="Barnsley K" first="Kathryn" last="Barnsley">Kathryn Barnsley</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, University of Tasmania, Hobart, Tasmania 7001, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Medicine, University of Tasmania, Hobart, Tasmania 7001</wicri:regionArea><wicri:noRegion>Tasmania 7001</wicri:noRegion></affiliation></author><author><name sortKey="Lu, Wenying" sort="Lu, Wenying" uniqKey="Lu W" first="Wenying" last="Lu">Wenying Lu</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author><author><name sortKey="Mcalinden, Kielan Darcy" sort="Mcalinden, Kielan Darcy" uniqKey="Mcalinden K" first="Kielan Darcy" last="Mcalinden">Kielan Darcy Mcalinden</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author><author><name sortKey="Eapen, Mathew Suji" sort="Eapen, Mathew Suji" uniqKey="Eapen M" first="Mathew Suji" last="Eapen">Mathew Suji Eapen</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author><author><name sortKey="Sohal, Sukhwinder Singh" sort="Sohal, Sukhwinder Singh" uniqKey="Sohal S" first="Sukhwinder Singh" last="Sohal">Sukhwinder Singh Sohal</name><affiliation wicri:level="1"><nlm:affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248</wicri:regionArea><wicri:noRegion>Tasmania 7248</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of clinical medicine</title><idno type="ISSN">2077-0383</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The epicenter of the original outbreak in China has high male smoking rates of around 50%, and early reported death rates have an emphasis on older males, therefore the likelihood of smokers being overrepresented in fatalities is high. In Iran, China, Italy, and South Korea, female smoking rates are much lower than males. Fewer females have contracted the virus. If this analysis is correct, then Indonesia would be expected to begin experiencing high rates of Covid-19 because its male smoking rate is over 60% (Tobacco Atlas). Smokers are vulnerable to respiratory viruses. Smoking can upregulate angiotensin-converting enzyme-2 (ACE2) receptor, the known receptor for both the severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV) and the human respiratory coronavirus NL638. This could also be true for new electronic smoking devices such as electronic cigarettes and "heat-not-burn" IQOS devices. ACE2 could be a novel adhesion molecule for SARS-CoV-2 causing Covid-19 and a potential therapeutic target for the prevention of fatal microbial infections, and therefore it should be fast tracked and prioritized for research and investigation. Data on smoking status should be collected on all identified cases of Covid-19.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32244852</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E841</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm9030841</ELocationID><Abstract><AbstractText>The epicenter of the original outbreak in China has high male smoking rates of around 50%, and early reported death rates have an emphasis on older males, therefore the likelihood of smokers being overrepresented in fatalities is high. In Iran, China, Italy, and South Korea, female smoking rates are much lower than males. Fewer females have contracted the virus. If this analysis is correct, then Indonesia would be expected to begin experiencing high rates of Covid-19 because its male smoking rate is over 60% (Tobacco Atlas). Smokers are vulnerable to respiratory viruses. Smoking can upregulate angiotensin-converting enzyme-2 (ACE2) receptor, the known receptor for both the severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV) and the human respiratory coronavirus NL638. This could also be true for new electronic smoking devices such as electronic cigarettes and "heat-not-burn" IQOS devices. ACE2 could be a novel adhesion molecule for SARS-CoV-2 causing Covid-19 and a potential therapeutic target for the prevention of fatal microbial infections, and therefore it should be fast tracked and prioritized for research and investigation. Data on smoking status should be collected on all identified cases of Covid-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brake</LastName><ForeName>Samuel James</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnsley</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Tasmania, Hobart, Tasmania 7001, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Wenying</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-1550-2276</Identifier><AffiliationInfo><Affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAlinden</LastName><ForeName>Kielan Darcy</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eapen</LastName><ForeName>Mathew Suji</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-0570-7059</Identifier><AffiliationInfo><Affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohal</LastName><ForeName>Sukhwinder Singh</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Tasmania 7248, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2 receptor</Keyword><Keyword MajorTopicYN="N">COPD</Keyword><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">Electronic cigarettes</Keyword><Keyword MajorTopicYN="N">Heat-Not-Burn</Keyword><Keyword MajorTopicYN="N">IQOS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Smoking</Keyword><Keyword MajorTopicYN="N">Vaping</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>03</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32244852</ArticleId><ArticleId IdType="pii">jcm9030841</ArticleId><ArticleId IdType="doi">10.3390/jcm9030841</ArticleId><ArticleId IdType="pmc">PMC7141517</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation><ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 2006 Jul 5;350(2):358-69</Citation><ArticleIdList><ArticleId IdType="pubmed">16519916</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Environ Res Public Health. 2014 Sep 17;11(9):9638-48</Citation><ArticleIdList><ArticleId IdType="pubmed">25233010</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Chest. 2017 Oct;152(4):899-900</Citation><ArticleIdList><ArticleId IdType="pubmed">28991543</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>JAMA Intern Med. 2017 Jul 1;177(7):1050-1052</Citation><ArticleIdList><ArticleId IdType="pubmed">28531246</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Sci (Lond). 2019 Jul 25;133(14):1663-1703</Citation><ArticleIdList><ArticleId IdType="pubmed">31346069</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Eur Respir J. 2018 Jan 31;51(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">29386338</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2005 May 31;102(22):7988-93</Citation><ArticleIdList><ArticleId IdType="pubmed">15897467</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Pathol. 2004 Jun;203(2):631-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2005 Jul 7;436(7047):112-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16001071</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Epidemiology. 2019 May;30(3):405-417</Citation><ArticleIdList><ArticleId IdType="pubmed">30789425</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Sci China Life Sci. 2020 Mar;63(3):457-460</Citation><ArticleIdList><ArticleId IdType="pubmed">32009228</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>ERJ Open Res. 2019 Feb 11;5(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">30775377</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Respir Crit Care Med. 2019 Jan 15;199(2):250-251</Citation><ArticleIdList><ArticleId IdType="pubmed">30290125</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Appl Gerontol. 2019 Jun;38(6):884-901</Citation><ArticleIdList><ArticleId IdType="pubmed">28653557</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Rev Cardiol. 2020 Mar 5;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>ERJ Open Res. 2019 Aug 12;5(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">31423449</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation><ArticleIdList><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Virol. 2020 Apr;92(4):433-440</Citation><ArticleIdList><ArticleId IdType="pubmed">31967321</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nicotine Tob Res. 2016 Aug;18(8):1684-96</Citation><ArticleIdList><ArticleId IdType="pubmed">26783291</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Sci (Lond). 2018 Feb 8;132(3):375-379</Citation><ArticleIdList><ArticleId IdType="pubmed">29439118</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Eur Respir J. 2018 Feb 7;51(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">29437942</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Eur Respir J. 2019 Oct 10;54(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">31601722</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect. 2019 Nov;79(5):401-406</Citation><ArticleIdList><ArticleId IdType="pubmed">31465780</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Antiviral Res. 2020 Apr;176:104742</Citation><ArticleIdList><ArticleId IdType="pubmed">32057769</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2005 Sep 16;309(5742):1864-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16166518</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Invest. 2008 Aug;118(8):2689-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18654673</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Med. 2005 Aug;11(8):875-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochim Biophys Acta. 2012 Jan;1824(1):186-94</Citation><ArticleIdList><ArticleId IdType="pubmed">21801859</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Australie</li></country></list><tree><country name="Australie"><noRegion><name sortKey="Brake, Samuel James" sort="Brake, Samuel James" uniqKey="Brake S" first="Samuel James" last="Brake">Samuel James Brake</name></noRegion><name sortKey="Barnsley, Kathryn" sort="Barnsley, Kathryn" uniqKey="Barnsley K" first="Kathryn" last="Barnsley">Kathryn Barnsley</name><name sortKey="Eapen, Mathew Suji" sort="Eapen, Mathew Suji" uniqKey="Eapen M" first="Mathew Suji" last="Eapen">Mathew Suji Eapen</name><name sortKey="Lu, Wenying" sort="Lu, Wenying" uniqKey="Lu W" first="Wenying" last="Lu">Wenying Lu</name><name sortKey="Mcalinden, Kielan Darcy" sort="Mcalinden, Kielan Darcy" uniqKey="Mcalinden K" first="Kielan Darcy" last="Mcalinden">Kielan Darcy Mcalinden</name><name sortKey="Sohal, Sukhwinder Singh" sort="Sohal, Sukhwinder Singh" uniqKey="Sohal S" first="Sukhwinder Singh" last="Sohal">Sukhwinder Singh Sohal</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003733 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003733 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:32244852
|texte= Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:32244852" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |